Tag: Vaccines
Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine
Difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization, severe COVID-19
Moderna Says Its Combo Vaccine Effective Against Omicron
Company says the combination vaccine triggers antibodies capable of fighting several variants, including beta and omicron
COVID-19 Response Coordinator Says Adults Older Than 60 Should Get Second Booster
The FDA authorized a second booster of the Pfizer and Moderna vaccines on March 29 for anyone 50 years and older
Adverse Effects Generally Mild After BNT162b2 mRNA Booster in Over 60s
Thirty percent of those aged 60 years or older receiving booster reported at least one AE; few sought medical attention
Physician’s Briefing Weekly Coronavirus Roundup
Overall Risk of Myopericarditis Low After COVID-19 Vaccine
Overall incidence of myopericarditis does not differ significantly for those receiving COVID-19 vaccines versus non-COVID-19 vaccines
COVID-19 Vaccine Largely Protects Cancer Patients
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies
Physician’s Briefing Weekly Coronavirus Roundup
Vaccination Mandate for Federal Workers Reinstated by Appeals Court
Mandate was introduced in September but enforcement was halted in January by a preliminary injunction issued by a federal judge in Texas
Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose; protection against infection waned
